These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6449096

  • 21. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M, Aurousseau MH, Rabiet MJ, Josso F.
    Thromb Res; 1982 Sep 15; 27(6):659-70. PubMed ID: 6217586
    [Abstract] [Full Text] [Related]

  • 22. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB, Rozenfel'd MA, Biriukova MI, Kostanova EA, Vasil'eva MV.
    Izv Akad Nauk Ser Biol; 2002 Sep 15; (5):522-7. PubMed ID: 12400374
    [Abstract] [Full Text] [Related]

  • 23. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y, Takada A.
    Thromb Res; 1989 Apr 15; 54(2):133-9. PubMed ID: 2526391
    [Abstract] [Full Text] [Related]

  • 24. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S.
    Biochem J; 1974 Nov 15; 143(2):273-83. PubMed ID: 4282470
    [Abstract] [Full Text] [Related]

  • 25. Degradation of human fibrinogen by plasmin: a kinetic study.
    Regañon E, Aznar J, Vila V.
    Thromb Res; 1977 Mar 15; 10(3):411-9. PubMed ID: 140473
    [No Abstract] [Full Text] [Related]

  • 26. The detection of neoantigenic sites on the D-dimer peptide isolated from plasmin digested cross linked fibrin.
    Lee-Own V, Gordon YB, Chard T.
    Thromb Res; 1979 Jan 15; 14(1):77-84. PubMed ID: 154752
    [No Abstract] [Full Text] [Related]

  • 27. [Structure and function of fibrinogen].
    Iwanaga S.
    Tanpakushitsu Kakusan Koso; 1969 Mar 15; 14(3):175-95. PubMed ID: 4240151
    [No Abstract] [Full Text] [Related]

  • 28. High-resolution two-dimensional electrophoretic analysis of fibrinogen digestion by plasmin.
    Ferguson EW.
    J Lab Clin Med; 1980 Oct 15; 96(4):710-21. PubMed ID: 6448274
    [No Abstract] [Full Text] [Related]

  • 29. [Immuno-nephelometric characterization of fibrinogen derivatives and of fibrin after chromatography].
    Haarsma M, Mensi N, Roth M, Bouvier CA.
    Schweiz Med Wochenschr; 1974 Sep 28; 104(39):1368-9. PubMed ID: 4279067
    [No Abstract] [Full Text] [Related]

  • 30. [Role of the K4 and K5 plasmin heavy chain kringles in the fibrin clot structure destruction].
    Andrianov SI, Makogonenko EM, Kudinov SA.
    Ukr Biokhim Zh (1978); 1992 Sep 28; 64(2):31-8. PubMed ID: 1413115
    [Abstract] [Full Text] [Related]

  • 31. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M, Chen JP.
    Thromb Haemost; 1984 Dec 29; 52(3):315-20. PubMed ID: 6241755
    [Abstract] [Full Text] [Related]

  • 32. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF, Edgington TS.
    J Clin Invest; 1975 Jul 29; 56(1):30-8. PubMed ID: 237938
    [Abstract] [Full Text] [Related]

  • 33. Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.
    Gaffney PJ.
    J Clin Pathol Suppl (R Coll Pathol); 1980 Jul 29; 14():10-7. PubMed ID: 6448869
    [No Abstract] [Full Text] [Related]

  • 34. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B, Shainoff JR.
    Biochim Biophys Acta; 1973 Mar 23; 303(1):161-70. PubMed ID: 4267201
    [No Abstract] [Full Text] [Related]

  • 35. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L, Boreisha IG, Arzadon L, Robbins KC.
    Thromb Res; 1977 Sep 23; 11(3):377-89. PubMed ID: 144332
    [No Abstract] [Full Text] [Related]

  • 36. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN, Gurewich V.
    J Clin Invest; 1991 Dec 23; 88(6):2012-7. PubMed ID: 1836471
    [Abstract] [Full Text] [Related]

  • 37. Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin.
    Kppeć M, Wegrzynowicz Z, Zajdel M, Sawecka J, Szumiel I.
    Thromb Res; 1974 Sep 23; 5(3):359-74. PubMed ID: 4280155
    [No Abstract] [Full Text] [Related]

  • 38. Subunit structure of the plasmin-induced degradation products of crosslinked fibrin.
    Gaffney PJ, Brasher M.
    Biochim Biophys Acta; 1973 Jan 25; 295(1):308-13. PubMed ID: 4265363
    [No Abstract] [Full Text] [Related]

  • 39. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
    Harpel PC, Gordon BR, Parker TS.
    Proc Natl Acad Sci U S A; 1989 May 25; 86(10):3847-51. PubMed ID: 2524834
    [Abstract] [Full Text] [Related]

  • 40. The relationship of fibrinogen structure to plasminogen activation and plasmin activity during fibrinolysis.
    Lucas MA, Fretto LJ, McKee PA.
    Ann N Y Acad Sci; 1983 Jun 27; 408():71-91. PubMed ID: 6223562
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.